Human CILP-1 C-Terminal Fragment Antibody, R&D Systems™

CILP-1

Polyclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

cartilage intermediate layer protein 1, cartilage intermediate layer protein 1 C1, cartilage intermediate layer protein 1 C2, cartilage intermediate layer protein, nucleotide pyrophosphohydrolase, Cartilage intermediate-layer protein, CILP, CILP1, CILP-1, HsT18872

Sheep

Affinity Purified

RUO

8483

Reconstitute at 0.2 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

Western Blot

LYOPH

Western Blot 0.1 ug/mL

O75339

CILP

Mouse myeloma cell line NS0-derived recombinant human CILP-1 C-Terminal Fragment Arg724-Asn1184 Accession # O75339

25 μg

Primary

Detects human CILP-1 C-Terminal Fragment in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant human CILP-1 N-terminal peptide is observed.

Human

IgG